Stereotaxis Inc (STXS)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Stereotaxis Inc Stock (STXS) Company Profile

Stereotaxis Inc

Healthcare (1110)

314-678-6100

4320 Forest Park Avenue, Suite 100, St. Louis, MO

@stereotaxis

Nächster Verdiensttermin

Neueste SEC-Einreichungen

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STXS Stereotaxis Inc	1.945	187.65M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	440.65	155.16B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	147.67	40.68B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.88	33.06B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	36.50	31.30B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	207.98	30.18B	5.54B	1.52B	1.74B	10.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-16	Eingeleitet	Citizens JMP	Mkt Outperform
2024-01-10	Eingeleitet	ROTH MKM	Buy
2022-07-12	Eingeleitet	Aegis Capital	Buy
2022-06-23	Eingeleitet	B. Riley Securities	Buy
2022-01-05	Eingeleitet	Craig Hallum	Buy
2022-01-05	Eingeleitet	Loop Capital	Buy
2021-05-26	Eingeleitet	Piper Sandler	Overweight
2020-09-08	Eingeleitet	Northland Capital	Outperform
2020-04-09	Eingeleitet	Cowen	Outperform
2020-04-07	Eingeleitet	Lake Street	Buy

Alle ansehen

Stereotaxis Inc Aktie (STXS) Neueste Nachrichten

Finanzdaten der Stereotaxis Inc-Aktie (STXS)

Stereotaxis Inc (STXS)

Stereotaxis Inc Stock (STXS) Company Profile

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Stereotaxis Inc Aktie (STXS) Neueste Nachrichten

Stereotaxis (STXS) Edges Higher: Navigating the Robotics Sector with Modest GainsVolatility Term Structure - Newser

Stereotaxis Emerges as Notable Oversold Play in AI Sector with Over 120 Percent Implied Upside - HarianBasis.co

Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why - Insider Monkey

Stereotaxis Inc. (STXS) Edges Higher as Stock Tests Key Resistance Near $2.02Shared Buy Zones - Newser

STXS Q1 2026 Earnings: Larger-Than-Expected Loss as Company Continues Strategic TransitionROA Comparison - Newser

5 Most Oversold AI Stocks to Buy According to Analysts - Insider Monkey

STXS News | STEREOTAXIS INC (NYSEARCA:STXS) - ChartMill

Stereotaxis stock up on first US MAGIC procedures post approval - MSN

Stereotaxis Q1 earnings call highlights - MSN

Stereotaxis to acquire Robocath for up to $45M - MSN

Stereotaxis Q1 Earnings Call Highlights - sharewise.com

Stereotaxis shareholders elect directors and approve key proposals at annual meeting - Investing.com India

Stereotaxis, Inc. touts robotic technology to address physician burnout and improve patient care - Traders Union

Lagoda Investment discloses 4.5% stake in Stereotaxis (STXS) - Stock Titan

Stereotaxis Q4 Loss Narrows, Revenue Rises - Moomoo

Stereotaxis (NYSE: STXS) holders back board, auditor and executive pay - Stock Titan

Stereotaxis Inc. (STXS) reports Q1 loss, lags revenue estimates - MSN

Stereotaxis reports early traction for new products as Robocath acquisition advances - The Business Journals

Stereotaxis, Inc. 1Q 2026: Revenue $6.29M, EPS $(0.06) — 10-Q Summary - TradingView

Stereotaxis (STXS) posts Q1 2026 loss and plans $20M Robocath acquisition - Stock Titan

STXS Reiterated by Piper Sandler -- Price Target Lowered to $3.5 - GuruFocus

Lake Street Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Stereotaxis, Inc. (AMEX:STXS) Q1 2026 Earnings Call Transcript - Insider Monkey

Stereotaxis expects annual revenue to surpass $40M with Q3 and Q4 above $10M as MAGiC and Synchrony ramp - MSN

Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigat - GuruFocus

Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigating Regulatory Wins and Revenue ... By GuruFocus - Investing.com Canada

Stereotaxis, Inc. (STXS) Reports Strong Q1 2026 Earnings and Gro - GuruFocus

Earnings call transcript: Stereotaxis Q1 2026 misses forecasts, stock dips - Investing.com India

Is Stereotaxis (STXS) Still 23.2% Undervalued After Q1 2026? EPS - GuruFocus

STXS: Regulatory wins and new product launches drive optimism for double-digit revenue growth in 2026 - TradingView

Earnings call transcript: Stereotaxis Q1 2026 misses forecasts, stock dips By Investing.com - Investing.com Nigeria

STXS: Transition to new robotic and catheter platforms drives optimism for double-digit growth in 2026 - TradingView

Stereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Stereotaxis Q1 2026 Earnings Call Transcript - Benzinga

Stereotaxis Inc (NYSEARCA:STXS) Slides 6% After Q1 Revenue Miss Despite Narrower-Than-Expected Loss - ChartMill

Stereotaxis Q1 Loss Narrows, Revenue Falls - marketscreener.com

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates - The Manila Times

Surgical robotics provider Stereotaxis' Q1 revenue misses analyst estimates - TradingView

STXS: FDA approvals and Robocath deal set stage for growth despite Q1 revenue decline - TradingView

Stereotaxis (NYSE: STXS) Q1 revenue dips as FDA clearances and Robocath deal advance - Stock Titan

Stereotaxis 1Q Loss/Shr 6c >STXS - Moomoo

TradingKey - TradingKey

Stereotaxis Q1 2026 earnings preview - MSN

TD Cowen Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $5 - Moomoo

STXS Stereotaxis revenue jumps 20 percent year-over-year to 32.4 million, profitability challenges persist.Market Perform - newser.com

STXS to acquire Robocath to lead in endovascular robotics market - MSN

Earnings Preview: Stereotaxis to Report Financial Results Post-market on May 12 - Moomoo

Finanzdaten der Stereotaxis Inc-Aktie (STXS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie STXS